Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 2/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.56 |
| ▸ | NSD2 | O96028 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | FABP4 | P15090 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | CNR1 | P21554 | 1/20 | 0.47 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.47 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | ALPL | P05186 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5166693 | 0.86 | NR3C2 (0.57) | SMN1; SMN2NSD2ALDH1A1L3MBTL1CYP1A2 | |
| SCHEMBL5166003 | 0.82 | SMN1; SMN2 (0.60) | SMN1; SMN2NSD2ALDH1A1L3MBTL1FABP4 | |
| SCHEMBL5167263 | 0.79 | SMN1; SMN2 (0.56) | SMN1; SMN2NSD2ALDH1A1L3MBTL1FABP4 | |
| SCHEMBL5891884 | 0.76 | SMN1; SMN2 (0.56) | SMN1; SMN2ALDH1A1L3MBTL1CYP1A2CYP2C19 | |
| SCHEMBL4662881 | 0.76 | CYP19A1 (0.84) | CYP19A1SMN1; SMN2NSD2ALDH1A1L3MBTL1 | |
| SCHEMBL120014 | 0.73 | CYP19A1 (0.84) | CYP19A1SMN1; SMN2ALDH1A1L3MBTL1CYP1A2 | |
| SCHEMBL5163905 | 0.72 | SMN1; SMN2 (0.55) | SMN1; SMN2ALDH1A1L3MBTL1FABP4CYP1A2 | |
| SCHEMBL7958982 | 0.72 | POLB (0.60) | SMN1; SMN2ALDH1A1L3MBTL1LMNA | |
| SCHEMBL28593071 | 0.72 | SMN1; SMN2 (0.50) | SMN1; SMN2ALDH1A1L3MBTL1LMNA | |
| SCHEMBL16715360 | 0.72 | ALDH1A1 (0.74) | SMN1; SMN2ALDH1A1FABP4CYP1A2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060135773-A1 | Trisubstituted nitrogen modulators of tyrosine phosphatases | METABASIS THERAPEUTICS, INC. | 2006-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060135773-A1 | Trisubstituted nitrogen modulators of tyrosine phosphatases | PTPA, PTPN1, PTPRS | CYP19A1 3934/4885SMN1; SMN2 3478/4885NSD2 807/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.